Why Phio Pharmaceuticals Stock Is Nosediving
Why Phio Pharmaceuticals Stock Is Nosediving
The shares available for purchase are part of previously registered stock offerings under Form S-1 and Form S-3.Phio Pharmaceuticals Corp (NASDAQ:PHIO) shares are trading lower by 40% to $0.95 Thursday afternoon after the company announced it will exercise warrants for $2.8 million in gross proceeds.
Phio Pharmicals Corp（納斯達克股票代碼：PHIO）週四下午股價下跌40％，至0.95美元，此前該公司宣佈將行使總收益爲280萬美元的認股權證。
Phio Pharmaceuticals announced that accredited investors agreed to exercise certain warrants to purchase over 2 million shares of the company's stock at a reduced price of $1.33 per share, originally issued between 2018 and 2023 at higher prices.
Phio Pharmicals宣佈，合格投資者同意行使某些認股權證，以每股1.33美元的降價購買該公司超過200萬股股票，該認股權證最初是在2018年至2023年間以更高的價格發行的。
The exercise of these warrants is expected to bring in around $2.8 million in gross proceeds for the company before factoring in fees and expenses.
在考慮費用和支出之前，這些認股權證的行使預計將爲公司帶來約280萬美元的總收益。
The shares available for purchase are part of previously registered stock offerings under Form S-1 and Form S-3.
可供購買的股票是先前根據表格S-1和S-3註冊的股票發行的一部分。
See Also: Phio Pharmaceuticals Announces Exercise of Warrants for $2.8 Million Gross Proceeds
另見：Phio Pharmicals宣佈行使認股權證，總收益爲280萬美元
According to data from Benzinga Pro, PHIO has a 52-week high of $12.27 and a 52-week low of $0.88.
根據Benzinga Pro的數據，PHIO創下52周高點12.27美元，52周低點0.88美元。
